iBio, Inc. (62) | Uncategorized (9)
Recent Contracts
-
Environmental Indemnity Agreement, dated November 1, 2021 by iBio CDMO LLC and iBio, Inc. in favor of Woodforest National Bank
(Filed With SEC on November 4, 2021)
-
Description of Securities of iBio, Inc
(Filed With SEC on September 28, 2021)
-
Second Amended and Restated Right of First Refusal and Co-Sale Agreement, dated August 23, 2021, by and among RubrYc Therapeutics, Inc. and certain investors
(Filed With SEC on August 27, 2021)
-
Director Offer Letter
(Filed With SEC on August 26, 2021)
-
Director Offer Letter
(Filed With SEC on June 9, 2021)
-
Description of Securities of iBio, Inc
(Filed With SEC on October 13, 2020)
-
Statement of Work 2, dated February 6, 2020, between the Company and Beijing CC-Pharming Ltd
(Filed With SEC on March 13, 2020)
-
Form of Leak-Out Agreement
(Filed With SEC on October 28, 2019)
-
Form of Leak-Out Agreement
(Filed With SEC on October 24, 2019)
